The Global Organ Transplantation Market is projected to attain a CAGR of 10.6 % during the forecast period from 2021- 2030.
Organ transplantation is referred as a medical procedure that involves the removal of an organ from one person (donor) to and surgically replacing a damaged or missing organ inside another person (recipient). The donated organ may be from a living donor, an animal, or a deceased donor, or in some cases an artificial is used.
The factors attributing to drive the global market are owing to the rising prevalence of chronic & renal diseases, overconsumption of alcohol, and unhealthy dietary habits which are expected to push the growth of the organ transplantation market. Organ failure occurs owing to numerous factors such as loss of blood, drug abuse, frivolous trauma among others. According to the report published by US Department of Health & Human Services, nearly 122,000 patients in the US are in queue to receive organs for transplantation in 2019. In addition, rising numbers of tissue banks and technologically advanced products are expected to augment the global organ transplantation market during the forecast period.
In the past few years, an increase in awareness for tissue and organ donation and registration is being conducted and its widespread popularity is projected to influence the market positively. In addition, support from government organizations has aided the acceptance of organ donation. Moreover, the rising incidence of organ failure, lack of a skilled workforce, shortage of organ availability, and high transplantation costs are expected to hinder the global organ transplantation market to a huge extent.
The Global Organ Transplantation Market is segmented by product type, organ type, end-user, and region. Based on product type, it is categorized into immunosuppressive drugs, tissue/organ products, and organ preservation solutions. By organ type, it is bifurcated into tissue and organ transplants. Tissue transplants are further segmented into vascular grafts, cornea, bone marrow, heart valve, bone grafts, skin grafts, and other tissues. Organ transplants is further bifurcated into liver transplant, lung transplant, kidney transplant, heart transplant, pancreas transplant, and other transplants. The end-user bifurcates into transplant centers, hospitals, and others. Based on regional insights, the global organ transplantation market is categorized into North America (US, Canada, Mexico, Rest of America), Asia Pacific (India, China, Rest of Asia Pacific), Europe (UK, Germany, Russia, Rest of Europe) and Rest of the world (Latin America and Middle East & Africa).
North America is leading the global market owing to the presence of well-developed healthcare facilities, numerous significant biotechnology companies, medical devices companies which include Medtronic, Stryker, Arthrex. Inc., Zimmer Biomet, Novartis AG among others.
Asia Pacific region is also projected for the highest growth during the forecast period owing to improving healthcare infrastructure, awareness by the government for organ donation, and research R&D activities on stem cells for the development of in-vitro tissues & organs in the economies such as Indonesia, India, China, among others.
Prominent players inducing the Global Organ Transplantation Market are Novartis International AG, Transonic, ASTELLAS PHARMA Inc., Organ OX Limited, Transplant Biomedical, Accord Healthcare GmbH, Pfizer Inc., GlaxoSmithKline Plc., Terumo Medical Corporation, Hoffmann-La Roche Ltd., Preservation Solutions Inc., Bio-Med PVT. Ltd., Trans Medic Inc., SANOFI, and VELOXIS Pharmaceuticals A/S among others.
Segmentation and Scope of the Global Organ Transplantation Market
Global Organ Transplantation Market is segmented by product type, organ type, end-user, and region.
By Product Type
By Organ Type
Rest of World
Middle East & Africa
Prominent players in the Global Organ Transplantation Market among other includes